Hipertensión arterial maligna: su incidencia en un quinquenio
Rodríguez Acosta, Regino; Betancourt Arniella, Jorge; Xavier Morey, Francis; Nicolau Mena, Orlando.
Arch. méd. Camaguey
; 6(3)jul.-sep. 2002. tab
Artículo en Español | CUMED | ID: cum-26964
Documentos relacionados
Nephrosclerosis in young patients with malignant hypertension.
[Severe hypertension: definition and patients profiles].
Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week.
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
[A study on malignant arterial hypertension: about 168 cases at the unit of nephrology-internal medecine of the University Hospital Center, Treichville, Abidjan].
Malignant Hypertension: Current Perspectives and Challenges.
Management of hypertensive crisis: British and Irish Hypertension Society Position document.
[Malignant hypertension: A bright future].
Prevalencia y características de los pacientes con hipertensión arterial resistente y enfermedad renal crónica
Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry.